Referenzen:
1. Apostolakis S, Sullivan RM, et al. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT(2)R(2) score. Chest. 2013; 144: 1555-63.
2. van Miert JHA, Bos S, et al. Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis. PloS one. 2018; 13: e0194208.
3. Borre ED, Goode A, et al. Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review. Thromb Haemost. 2018; 118: 2171-87.
5. Zulkifly H, Lip GYH, et al. Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism. The American Journal of Cardiology. 2017; 120: 1139-45.
6. Zulkifly H, Lip GYH, et al. Use of the SAMe-TT2R2 score to predict anticoagulation control in atrial fibrillation and venous thromboembolism patients receiving vitamin K antagonists: A review. Heart Rhythm : the official journal of the Heart Rhythm Society. 2018; 15: 615-23.